Showing 71,481 - 71,500 results of 112,774 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((mean decrease) OR (a decrease)) ))', query time: 2.53s Refine Results
  1. 71481

    Thermally Induced Magnetic Anomalies in Solvates of the Bis(hexafluoroacetylacetonate)copper(II) Complex with Pyrazolyl-Substituted Nitronyl Nitroxide by Victor I. Ovcharenko (1565326)

    Published 2008
    “…We succeeded in synthesizing of a whole family of isostructural solvates of the copper(II) hexafluoroacetylacetonate complex with pyrazolyl-substituted nitronyl nitroxide (L): Cu(hfac)<sub>2</sub>L·0.5Solv. …”
  2. 71482

    Thermally Induced Magnetic Anomalies in Solvates of the Bis(hexafluoroacetylacetonate)copper(II) Complex with Pyrazolyl-Substituted Nitronyl Nitroxide by Victor I. Ovcharenko (1565326)

    Published 2008
    “…We succeeded in synthesizing of a whole family of isostructural solvates of the copper(II) hexafluoroacetylacetonate complex with pyrazolyl-substituted nitronyl nitroxide (L): Cu(hfac)<sub>2</sub>L·0.5Solv. …”
  3. 71483

    Thermally Induced Magnetic Anomalies in Solvates of the Bis(hexafluoroacetylacetonate)copper(II) Complex with Pyrazolyl-Substituted Nitronyl Nitroxide by Victor I. Ovcharenko (1565326)

    Published 2008
    “…We succeeded in synthesizing of a whole family of isostructural solvates of the copper(II) hexafluoroacetylacetonate complex with pyrazolyl-substituted nitronyl nitroxide (L): Cu(hfac)<sub>2</sub>L·0.5Solv. …”
  4. 71484

    Neutralization of endosomes by ammonium chloride reduces fusion induced by EBOV GP. by Ruben M. Markosyan (277036)

    Published 2016
    “…<p><b>(A)</b> Adding chloroquine (100 μM) or NH<sub>4</sub>Cl (10 mM) to the bathing solution greatly reduced EBOV GP-induced fusion after a pH 5.7 pulse (first set of three bars, endogenous cleavage (i.e., without thermolysin treatment) was employed. …”
  5. 71485

    JIL-1 act as suppressor of TPE over the TAS domain. by Rute Silva-Sousa (111978)

    Published 2013
    “…<p>(<b>A</b>) TPE assays in the TAS domain were performed with the reporter lines 39C-5 (chromosome 2L, TAS-L) and 39C-27 (chromosome 2R, TAS-R). …”
  6. 71486

    Increased Response to Glutamate in Small Diameter Dorsal Root Ganglion Neurons after Sciatic Nerve Injury by Kerui Gong (429477)

    Published 2014
    “…Western blot analysis of the DRGs revealed that CCI resulted in a 35% increase in GluA1 and a 60% decrease in GluA2, the AMPA receptor subunits, compared to uninjured controls. mGluR1 receptor expression increased by 60% in the membrane fraction, whereas mGluR5 receptor subunit expression remained unchanged after CCI. …”
  7. 71487

    Effect of BLT1 blockade on mechanical withdrawal threshold after plantar incision. by Miho Asahara (436600)

    Published 2022
    “…The withdrawal thresholds of the ipsilateral paw decreased in both BLT1KO and BLT1WT mice. Data are shown as means ± SEM (n = 15–16 per group). …”
  8. 71488

    Lowering oxygen exposure reduces oxidative stress, DNA damage and genomic instability in thymus. by Ho Joong Sung (221317)

    Published 2011
    “…Data shown as mean ± SEM, with n = 5. <b>C.</b> Representative images of decreased oxidative DNA damage detected by avidin-FITC (Av-FITC) staining for 8-oxoG in thymus tissue from <i>p53−/−</i> mouse exposed to 10% versus 21% oxygen for 2 to 4 wk. …”
  9. 71489

    Table3_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  10. 71490

    Table4_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  11. 71491

    Table7_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  12. 71492

    Table9_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  13. 71493

    Table6_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  14. 71494

    Data_Sheet_1_Aerosols and Bacteria From Hand Washing and Drying in Indoor Air.PDF by Maria Salomé Gião (12050771)

    Published 2022
    “…The concentration of aerosols decreased with particle size, with maximum concentrations after drying hands of 6.63 × 10<sup>6</sup> ± 6.49 × 10<sup>5</sup> and 2.28 × 10<sup>4</sup> ± 9.72 × 10<sup>3</sup> particles m<sup>−3</sup> for sizes 0.3 to <0.5 and ≥5.0 μm, respectively. …”
  15. 71495

    Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection by Liang Cui (446525)

    Published 2018
    “…We performed a mass spectrometry-based metabolomic profiling of sera from adult DF and DHF patients at the critical and recovery phases of infection. …”
  16. 71496

    Table8_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  17. 71497

    Table1_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).XLSX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  18. 71498

    Table2_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  19. 71499

    Impact of modifications to periplasmic volume around optimal solution of ABC cell at nutrient concentration of 1 nM. by Noele Norris (10826554)

    Published 2021
    “…<p>To understand why the periplasm inflates as the nutrient concentration decreases to 1 nM, we plot the proportion of bound transport units (A) and effective half-saturation constant, K<sub>M</sub>, (B) as we modify the periplasmic volume of the optimal solution for a nutrient concentration of 1 nM. …”
  20. 71500

    Validation of mitochondrial Ca<sup>2+</sup> measurements. by Yael Yaniv (162548)

    Published 2012
    “…<p>(A) Mn<sup>2+</sup> (50 µmol/L) quenching of the cytosolic Indo-1 fluorescence ratio 410/490 (top panel), and fluorescence emission at wavelengths of 410 (middle panel), and 490 nm (lower panel). …”